Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Cancer Prevention Month: Get ACRO Health Gift Cards! Cancer Prevention Month: Get ACRO Health Gift Cards!
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
FC6-M82E0 | Mouse | Biotinylated Mouse Fc gamma RIII / CD16 Protein, His,Avitag™ (MALS & SPR verified) |
|
|
|
FC6-R52H6 | Rhesus macaque | Rhesus macaque Fc gamma RIII / CD16 Protein, His Tag (SPR & BLI & MALS verified) |
|
|
|
FC6-C82E0 | Cynomolgus | Biotinylated Cynomolgus Fc gamma RIII / CD16 Protein, His,Avitag™ (MALS & BLI verified) |
|
|
|
FC6-C52H9 | Cynomolgus | Cynomolgus Fc gamma RIII / CD16 Protein, His Tag (MALS & BLI verified) |
|
|
|
CDA-M52H8 | Mouse | Mouse Fc gamma RIII / CD16 Protein, His Tag (SPR & BLI & MALS verified) |
|
|
Biotinylated Mouse CD16, His,Avitag (Cat. No. FC6-M82E0) captured on Biotin CAP- Series S Sensor Chip can bind Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3) with an affinity constant of 0.345 μM as determined in a SPR assay (Biacore T200) (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
FT-538 | FT-538 | Phase 2 Clinical | Fate Therapeutics Inc | Leukemia, Myeloid; Ovarian Neoplasms; Solid tumours; HIV Infections; Coronavirus Disease 2019 (COVID-19); Neoplasms; Respiratory Distress Syndrome, Adult; Peritoneal Neoplasms; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Fallopian Tube Neoplasms | Details |
GMA-161 | GMA-161 | Phase 1 Clinical | Sanofi, Macrogenics Inc | Purpura, Thrombocytopenic, Idiopathic | Details |
SAR445514 | SAR445514; SAR-445514; IPH6401/SAR514 | Phase 2 Clinical | Sanofi | Immunoglobulin Light-chain Amyloidosis; Multiple Myeloma | Details |
Acimtamig | AFM-13 | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center | Lymphoma, T-Cell, Peripheral; Hodgkin Disease; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Mycosis Fungoides | Details |
FT-516 | FT-516 | Phase 1 Clinical | University Of Minnesota, Fate Therapeutics Inc | Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Abdominal Neoplasms; Coronavirus Disease 2019 (COVID-19); Leukemia, Myeloid, Acute; Fallopian Tube Neoplasms | Details |
AFM-28 | AFM-28 | Phase 1 Clinical | Affimed | Leukemia, Promyelocytic, Acute; Neoplasms; Leukemia, Myeloid, Acute | Details |
AFM-24 | AFM-24 | Phase 2 Clinical | Affimed | Solid tumours | Details |
FT-576 | FT-576 | Phase 1 Clinical | University Of Minnesota, Fate Therapeutics Inc | Bone Marrow Neoplasms; Multiple Myeloma | Details |
SM-3321 | SM-3321; SM3321 | Phase 1 Clinical | Beijing StarMab BioMed Technology Ltd | Solid tumours; Neoplasms; Leukemia, Myeloid, Acute | Details |
FT-596 | FT-596 | Phase 1 Clinical | Fate Therapeutics Inc | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
SAR-443579 | SAR-443579; SAR443579; SAR579; IPH6101; IPH-6101 | Phase 2 Clinical | Sanofi | Hematologic Diseases; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details |
IPH-6501 | IPH-6501; IPH-65 | Phase 2 Clinical | Innate Pharma SA | Neoplasms; Lymphoma, Non-Hodgkin | Details |
This web search service is supported by Google Inc.